|
1.
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar
|
|
2.
|
Nagini S: Carcinoma of the stomach: a
review of epidemiology, pathogenesis, molecular genetics and
chemoprevention. World J Gastrointest Oncol. 4:156–169. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Danaei G, Vander Hoorn S, Lopez AD, Murray
CJ and Ezzati M; Comparative Risk Assessment collaborating group
(Cancers): Causes of cancer in the world: comparative risk
assessment of nine behavioural and environmental risk factors.
Lancet. 366:1784–1793. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Catalano V, Labianca R, Beretta GD, Gatta
G, de Braud F and Van Cutsem E: Gastric cancer. Crit Rev Oncol
Hematol. 71:127–164. 2009. View Article : Google Scholar
|
|
5.
|
Kim BS, Cho SW, Min SK and Lee BH:
Differences in prognostic factors between early and advanced
gastric cancer. Hepatogastroenterology. 58:1032–1040.
2011.PubMed/NCBI
|
|
6.
|
Seshadri RA, Jayanand SB and Ranganathan
R: Prognostic factors in patients with node-negative gastric
cancer: an Indian experience. World J Surg Oncol. 9:482011.
View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Qiu MZ, Wang ZQ, Luo HY, et al: Prognostic
analysis in node-negative gastric cancer patients in China. Tumour
Biol. 32:489–492. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Murata K, Miyoshi E, Kameyama M, et al:
Expression of N-acetylglucosaminyltransferase V in colorectal
cancer correlates with metastasis and poor prognosis. Clin Cancer
Res. 6:1772–1777. 2000.PubMed/NCBI
|
|
9.
|
Guo P, Chen HJ, Wang QY and Chen HL:
Downregulation of N-acetylglucosaminyltransferase V facilitates
all-trans retinoic acid to induce apoptosis of human
hepatocarcinoma cells. Mol Cell Biochem. 284:103–110. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Xu YY, Lu Y, Fan KY and Shen ZH: Apoptosis
induced by all-trans retinoic acid in
N-acetylglucosaminyltransferase V repressed human hepatocarcinoma
cells is mediated through endoplasmic reticulum stress. J Cell
Biochem. 100:773–782. 2007. View Article : Google Scholar
|
|
11.
|
Dosaka-Akita H, Miyoshi E, Suzuki O, Itoh
T, Katoh H and Taniguchi N: Expression of
N-acetylglucosaminyltransferase V is associated with prognosis and
histology in non-small cell lung cancers. Clin Cancer Res.
10:1773–1779. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Ishimura H, Takahashi T, Nakagawa H, et
al: N-acetylglucosaminyltransferase V and beta1-6 branching
N-linked oligosaccharides are associated with good prognosis of
patients with bladder cancer. Clin Cancer Res. 12:2506–2511. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Inamori K, Gu J, Ohira M, et al: High
expression of N-acetylglucosaminyltransferase V in favorable
neuroblastomas: involvement of its effect on apoptosis. FEBS Lett.
580:627–632. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Tian H, Miyoshi E, Kawaguchi N, et al: The
implication of N-acetylglucosaminyltransferase V expression in
gastric cancer. Pathobiology. 75:288–294. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Pinho SS, Figueiredo J, Cabral J, et al:
E-cadherin and adherens-junctions stability in gastric carcinoma:
functional implications of glycosyltransferases involving N-glycan
branching biosyn-thesis, N-acetylglucosaminyltransferases III and
V. Biochim Biophys Acta. 1830:2690–2700. 2013. View Article : Google Scholar
|
|
16.
|
Wei T, Liu Q, He F, Zhu W, Hu L, Guo L and
Zhang J: The role of N-acetylglucosaminyltransferases V in the
malignancy of human hepatocellular carcinoma. Exp Mol Pathol.
93:8–17. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Yang HM, Yu C and Yang Z:
N-acetylglucosaminyltransferase V negatively regulates integrin
α5β1-mediated monocyte adhesion and transmigration through vascular
endothelium. Int J Oncol. 41:589–598. 2012.PubMed/NCBI
|
|
18.
|
Pinho SS, Seruca R, Gärtner F, Yamaguchi
Y, Gu J, Taniguchi N and Reis CA: Modulation of E-cadherin function
and dysfunction by N-glycosylation. Cell Mol Life Sci.
68:1011–1020. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Kim YS, Hwang SY, Kang HY, et al:
Functional proteomics study reveals that
N-Acetylglucosaminyltransferase V reinforces the
invasive/metastatic potential of colon cancer through aberrant
glycosylation on tissue inhibitor of metalloproteinase-1. Mol Cell
Proteomics. 7:1–14. 2008. View Article : Google Scholar
|
|
20.
|
Abbott KL, Aoki K, Lim JM, et al: Targeted
glycoproteomic identification of biomarkers for human breast
carcinoma. J Proteome Res. 7:1470–1480. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Guo HB, Randolph M and Pierce MJ:
Inhibition of a specific N-glycosylation activity results in
attenuation of breast carcinoma cell invasiveness-related
phenotypes: inhibition of epidermal growth factor-induced
dephosphorylation of focal adhesion kinase. Biol Chem.
282:22150–22162. 2007. View Article : Google Scholar
|
|
22.
|
Miyoshi E, Nishikawa A, Ihara Y, et al:
N-acetylglucosaminyltransferase III and V messenger RNA levels in
LEC rats during hepatocarcinogenesis. Cancer Res. 53:3899–3902.
1993.PubMed/NCBI
|
|
23.
|
Miyoshi E, Ihara Y, Nishikawa A, et al:
Gene expression of N-acetylglucosaminyltransferases III and V: a
possible implication for liver regeneration. Hepatology.
22:1847–1855. 1995.PubMed/NCBI
|
|
24.
|
Yao M, Zhou DP, Jiang SM, Wang QH, Zhou
XD, Tang ZY and Gu JX: Elevated activity of
N-acetylglucosaminyltransferase V in human hepatocellular
carcinoma. J Cancer Res Clin Oncol. 124:27–30. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
25.
|
Buckhaults P, Chen L, Fregien N and Pierce
M: Transcriptional regulation of N-acetylglucosaminyltransferase V
by the src oncogene. J Biol Chem. 272:19575–19581. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
26.
|
Lu Y and Chaney W: Induction of
N-acetylglucosaminyltran sferase V by elevated expression of
activated or proto-Ha-ras oncogenes. Mol Cell Biochem. 122:85–92.
1993. View Article : Google Scholar : PubMed/NCBI
|
|
27.
|
Pierce M, Buckhaults P, Chen L and Fregien
N: Regulation of N-acetylglucosaminyltransferase V and Asn-linked
oligosaccharide beta(1,6) branching by a growth factor signaling
pathway and effects on cell adhesion and metastatic potential.
Glycoconj J. 14:623–630. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
28.
|
Przybyło M, Pocheć E, Link-Lenczowski P
and Lityńska A: Beta 1-6 branching of cell surface glycoproteins
may contribute to uveal melanoma progression by up-regulating cell
motility. Mol Vis. 14:625–636. 2008.PubMed/NCBI
|
|
29.
|
Demetriou M, Nabi IR, Coppolino M, Dedhar
S and Dennis JW: Reduced contact-inhibition and substratum adhesion
in epithelial cells expressing GlcNAc-transferase V. J Cell Biol.
130:383–392. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
30.
|
Seberger PJ and Chaney WG: Control of
metastasis by Asnlinked, β-6 branched oligosaccharides in mouse
mammary cancer cells. Glycobiology. 9:235–241. 1999.
|
|
31.
|
Zhao Y, Sato Y, Isaji T, et al: Branched
N-glycans regulate the biological functions of integrins and
cadherins. FEBS J. 275:1939–1948. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
32.
|
Gu J and Taniguchi N: Potential of
N-glycan in cell adhesion and migration as either a positive or
negative regulator. Cell Adh Migr. 2:243–245. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
33.
|
Isaji T, Kariya Y, Xu Q, Fukuda T,
Taniguchi N and Gu J: Functional roles of the bisecting GlcNAc in
integrin-mediated cell adhesion. Methods Enzymol. 480:445–459.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
34.
|
Ye Q, Kantonen S and Gomez-Cambronero J:
Serum deprivation confers the MDA-MB-231 breast cancer line with an
EGFR/JAK3/PLD2 system that maximizes cancer cell invasion. J Mol
Biol. 425:755–766. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
35.
|
Lau KS and Dennis JW: N-Glycans in cancer
progression. Glycobiology. 18:750–760. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
36.
|
Atmaca A, Werner D, Pauligk C, et al: The
prognostic impact of epidermal growth factor receptor in patients
with metastatic gastric cancer. BMC Cancer. 12:5242012. View Article : Google Scholar : PubMed/NCBI
|
|
37.
|
Nan BC, Shao DM, Chen HL, Huang Y, Gu JX,
Zhang YB and Wu ZG: Alteration of N-acetylglucosaminyltransferases
in pancreatic carcinoma. Glycoconj J. 15:1033–1037. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
38.
|
Shaheen PE, Stadler W, Elson P, Knox J,
Winquist E and Bukowski RM: Phase II study of the efficacy and
safety of oral GD0039 in patients with locally advanced or
metastatic renal cell carcinoma. Invest New Drugs. 23:577–581.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
39.
|
Taylor JB, Strickland J, May T and Hawkins
DE: Effect of subacute swainsonine (locoweed; Oxytropis
sericea) consumption on immunocompetence and serum constituents
of sheep in a nutrient-restricted state. Vet Hum Toxicol.
42:199–204. 2000.PubMed/NCBI
|
